The Syapse Network is dedicated to improving cancer care across communities by bringing real-world evidence to the point of care to support physicians’ decision-making process.
Precision medicine represents an exciting opportunity to rapidly advance the state of cancer care. By using molecular profiling and targeted therapies / immunotherapy, oncologists can achieve meaningful survival and quality of life gains for their patients. However, knowing which treatment to use, and also which treatments not to use, in response to complex molecular results is very difficult. Oncologists currently rely on personal experiences and clinical guidelines. However, new knowledge for the clinical utility of precision medicine is being generated at a rapid rate, making it difficult for physicians to keep up.
With the Syapse Network, oncologists will have the power of a learning health system—one that brings together insights from a network of leading health systems, and integrates that knowledge right into their decision-making process at the point of care. Oncologists and expert bodies such as molecular tumor boards will be able to use insights from the largest precision oncology data sharing network to support treatment selection, with access to clinical, molecular, treatment and outcomes data at a scale never seen before.